RECURSION PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
RECURSION PHARMACEUTICALS, INC. (RXRX) had Property, Plant and Equipment, Gross of $193.15 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-25
- 2025-12-31: Property, Plant and Equipment, Gross $193.15M.
- 2024-12-31: Property, Plant and Equipment, Gross $203.73M.
- 2024-09-30: Property, Plant and Equipment, Gross $140.88M.
- 2024-06-30: Property, Plant and Equipment, Gross $136.08M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $193.15M 10-K · filed 2026-02-25 |
| 2024-12-31 | $203.73M 10-K · filed 2026-02-25 |
| 2024-09-30 | $140.88M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $136.08M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $135.57M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $131.38M 10-K · filed 2025-02-28 |
| 2023-09-30 | $127.09M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $127.37M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $123.64M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $118.31M 10-K · filed 2024-02-29 |
| 2022-09-30 | $112.83M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $105.65M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $92.13M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $83.46M 10-K · filed 2023-02-27 |
| 2021-09-30 | $71.66M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $62.31M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $56.04M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $35.93M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |